Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial

GONZALEZ-SARRIAS, ASIM; GARCIA-VILLALBA, Rocio; ROMO-VAQUERO, Maria; ALAŞALVAR, Cesarettin; Orem, Asimo; ZAFRILLA, Pilar; TOMAS-BARBERAN, Francisco; SELMA, Maria; CARLOS ESPIN, Juan

doi:10.1002/mnfr.201600830

Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial

Copy For Citation

GONZALEZ-SARRIAS A., GARCIA-VILLALBA R., ROMO-VAQUERO M., ALAŞALVAR C., Orem A., ZAFRILLA P., ...More

MOLECULAR NUTRITION & FOOD RESEARCH, vol.61, no.5, 2017 (SCI-Expanded)

Publication Type: Article / Article
Volume: 61 Issue: 5
Publication Date: 2017
Doi Number: 10.1002/mnfr.201600830
Journal Name: MOLECULAR NUTRITION & FOOD RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Keywords: Cardiometabolic, EFSA, Gut microbiota, Metabotype, Urolithins, METABOLIC SYNDROME, DOUBLE-BLIND, MICROBIOTA, ELLAGITANNINS, CONSUMPTION, ANTIOXIDANT, LDL, MEN, METAANALYSIS, PREVENTION
Karadeniz Technical University Affiliated: Yes

Abstract

Scope: The pomegranate lipid-lowering properties remain controversial, probably due to the interindividual variability in polyphenol (ellagitannins) metabolism.